All WSe [electronic resource]
By: Contributor(s): Publication details: Nature communications 11 2019Description: 5201 p. digitalISSN:- 2041-1723
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
-
1
Chemoselective Glycosylations. 2. Differences in Size of Anomeric Leaving Groups Can Be Exploited in Chemoselective Glycosylations.
by Geurtsen, Richard -
2
Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro-drug of miridesap.
by Richards, Duncan -
3
Prevalence of Lead Hazards and Soil Arsenic in U.S. Housing.
by Dewalt, F Gary -
4
p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
by Aston, Nicola M -
5
Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome.
by White, Gemma V -
6
The discovery of quinoline based single-ligand human H
by Procopiou, Panayiotis A -
7
Design of Phthalazinone Amide Histamine H
by Procopiou, Panayiotis A -
8
Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H
by Procopiou, Panayiotis A -
9
Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome.
by Thorpe, James H -
10
Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome.
by Walker, Ann L -
11
Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
by Procopiou, Panayiotis A -
12
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase.
by Hutchinson, Jonathan P -
13
Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.
by Angell, Richard -
14
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.
by McBride, Andrew -
15
4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
by Liddle, John -
16
Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.
by Walker, Ann L -
17
Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675].
by Walker, Ann L -
18
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen Presentation.
by Liddle, John -
19
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis.
by Walker, Ann L -
20
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.
by Liddle, John
All WSe
APA
Sivan M., Li Y., Veluri H., Zhao Y., Tang B., Wang X., Zamburg E., Leong J. F., Niu J. X., Chand U. & Thean A. V. (112019). All WSe. : Nature communications.
Chicago
Sivan Maheswari, Li Yida, Veluri Hasita, Zhao Yunshan, Tang Baoshan, Wang Xinghua, Zamburg Evgeny, Leong Jin Feng, Niu Jessie Xuhua, Chand Umesh and Thean Aaron Voon-Yew. 112019. All WSe. : Nature communications.
Harvard
Sivan M., Li Y., Veluri H., Zhao Y., Tang B., Wang X., Zamburg E., Leong J. F., Niu J. X., Chand U. and Thean A. V. (112019). All WSe. : Nature communications.
MLA
Sivan Maheswari, Li Yida, Veluri Hasita, Zhao Yunshan, Tang Baoshan, Wang Xinghua, Zamburg Evgeny, Leong Jin Feng, Niu Jessie Xuhua, Chand Umesh and Thean Aaron Voon-Yew. All WSe. : Nature communications. 112019.